Tag Archives: Millendo Therapeutics Inc

Wedbush Keeps a Buy Rating on Millendo Therapeutics Inc (MLND)

Wedbush analyst Laura Chico reiterated a Buy rating on Millendo Therapeutics Inc (MLND – Research Report) yesterday and set a price target of $24. The company’s shares closed last Monday at $6.97, close to its 52-week low of $6.77. According